Rhenium(I) polypyridine complexes coordinated to an ethyl-isonicotinate ligand: Luminescence and in vitro anti-cancer studies

doi:10.1016/j.ica.2019.119329

Paper

Rhenium(I) polypyridine complexes coordinated to an ethyl-isonicotinate ligand: Luminescence and in vitro anti-cancer studies

Published Feb 1, 2020 · Luiz D. Ramos, G. Cerchiaro, Karina P. M. Frin

Inorganica Chimica Acta

Q2 SJR score

15

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Rhenium(I) complexes with ethyl-isonicotinate ligands show potential as novel anticancer agents, generating singlet oxygen in the presence of light and killing cancer cells through a different mechanism of action in the absence of light.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Rhenium(I) polypyridine complexes coordinated to an ethyl-isonicotinate ligand: Luminescence and in vitro anti-cancer studies

References

Citations